91Ö±²¥

All publications

Journal articles

• Hernández Alava M, Pudney SE & Wailoo AJ (2023) . Value in Health.
• Gray LA, Hernandez Alava M & Wailoo AJ (2022) . BMC Cancer, 22(1).
• Hussain H, Keetharuth A, Rowen D & Wailoo A (2022) . Health and Quality of Life Outcomes, 20(1).
• Girling C, Lee MJ, Vimalchandran D, Jayne DJ, Stancliffe S, Wailoo A, Bradburn M, Hind D, Bursnall M, Robinson LK & Brown SR (2022) . Techniques in Coloproctology.
• Peasgood T, Mukuria C, Rowen D, Tsuchiya A & Wailoo A (2022) . Value in Health.
• Rowen D, Wickramasekera N, Hole A, Keetharuth D & Wailoo A (2022) . Value in Health.
• Gomes M, Latimer N, Soares M, Dias S, Baio G, Freemantle N, Dawoud D, Wailoo A & Grieve R (2022) . PharmacoEconomics.
• Scott DL, Ibrahim F, Hill H, Tom B, Prothero L, Baggott RR, Bosworth A, Galloway JB, Georgopoulou S, Martin N , Neatrour I et al (2021) . Programme Grants for Applied Research, 9(8).
• Wailoo A, Alava MH, Pudney S, Barton G, O’Dwyer J, Gomes M, Irvine L, Meads D & Sadique Z (2021) . Value in Health.
• Rowen D, Keetharuth D, Poku E, Wong R, Pennington R & Wailoo A (2020) . Value in Health.
• Scott D, Ibrahim F, Hill H, Tom B, Prothero L, Baggott RR, Bosworth A, Galloway JB, Georgopoulou S, Martin N , Neatrour I et al (2020) . Seminars in Arthritis and Rheumatism, 50(5), 1182-1190.
• Hernandez M, Wailoo A, Chrysanthou G, Carvalho P, Van der Heijde D, Santos MJ & Machado PM (2020) . Annals of the Rheumatic Diseases, 79(Suppl 1), 52.1-53.
• Hill J, Pennington R, Wailoo A, Wong R & Rowen D (2020) . Value in Health.
• Hernandez Alava M, Pudney S & Wailoo A (2020) . Value in Health.
• Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Embleton N, Graham R, Hart AR, Jarvis D, Kilby MD, Lie M , Mason G et al (2019) . Health Technology Assessment, 23(49), 1-144.
• Kristensen FB, Husereau D, Huić M, Drummond M, Berger ML, Bond K, Augustovski F, Booth A, Bridges JFP, Grimshaw J , IJzerman MJ et al (2019) . Value in Health, 22(1), 13-20.
• (2018) . Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis, 38(4), 314-314.
• Gray LA, Wailoo A & Hernandez M (2018) . Value in Health.
• Pennington B, Hernandez-Alava M, Pudney S & Wailoo A (2018) . PharmacoEconomics.
• Gray LA, Hernandez M & Wailoo AJ (2018) . Value in Health, 21(6), 748-757.
• Shah K, Tsuchiya A & Wailoo A (2018) . Social Science & Medicine, 204, 39-50.
• Simpson EL, Hock E, Stevenson M, Wong R, Dracup N, Wailoo A, Conaghan PG, Estrach C, Edwards CJ & Wakefield RJ (2018) . Health Technology Assessment, 22(20).
• Hernandez Alava M, Wailoo A, Grimm S, Pudney S, Gomes M, Sadique Z, Meads D, O’Dwyer J, Barton G & Irvine L (2018) . Value in Health, 21(1), 49-56.
• Martin NH, Ibrahim F, Tom B, Galloway J, Wailoo A, Tosh J, Lempp H, Prothero L, Georgopoulou S, Sturt J , Scott DL et al (2017) . Trials, 18(1), 591-591.
• Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC & Wailoo A (2017) . Obstetric Anesthesia Digest, 37(4), 202-203.
• Wailoo A, Hock ES, Stevenson M, Martyn-St James M, Rawdin A, Simpson E, Wong R, Dracup N, Scott DL & Young A (2017) . Health Technology Assessment, 21(71), 1-258.
• Grimm SE, Strong M, Brennan A & Wailoo A (2017) . PharmacoEconomics, 35(12), 1287-1296.
• Briggs V, Solis-Trapala I, Wailoo A, McCullough K, Lambie M, Caskey FJ, Fotheringham J, Davies SJ & Wilkie M (2017) . Peritoneal Dialysis International.
• Gullick NJ, Mian AN, Ibrahim F, Walker D, Hassell A, Kiely PDW, Walsh DA, Young A, Scott DL, Lempp H , Sturt J et al (2017) Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data. Clinical and Experimental Rheumatology, 35(5), 810-815.
• Johannesen KM, Claxton K, Sculpher MJ & Wailoo AJ (2017) . Health Economics.
• Stevenson MD, Wailoo AJ, Tosh JC, Hernandez-Alava M, Gibson LA, Stevens JW, Archer RJ, Simpson EL, Hock ES, Young A & Scott DL (2017) . Journal of Rheumatology, 44(7), 973-980.
• Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC & Wailoo A (2017) . Obstetrical & Gynecological Survey, 72(6), 323-325.
• Griffiths PD, Bradburn M, Campbell MJ, Connolly DJA, Cooper CL, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC & Wailoo A (2017) . Clinical Radiology.
• Alshreef A, Wailoo AJ, Brown SR, Tiernan JP, Watson AJM, Biggs CE, Bradburn M & Hind D (2017) . PharmacoEconomics Open.
• Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, Akehurst RL & Campbell MJ (2017) . Statistical Methods in Medical Research, 26(2), 724-751.
• Wailoo AJ, hernandez M, manca A, mejia A, Ray J, crawford B, botteman M & busschbach J (2017) . Value in Health, 20(1), 18-27.
• Griffiths PD, Bradburn M, Campbell MJ, Cooper CL, Graham R, Jarvis D, Kilby MD, Mason G, Mooney C, Robson SC , Wailoo A et al (2016) . The Lancet, 389(10068), 538-546.
• Luqmani R, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W , Masters S et al (2016) . Health Technology Assessment, 20(90).
• Brown S, Tiernan J, Biggs K, Hind D, Shephard N, Bradburn M, Wailoo A, Alshreef A, Swaby L, Watson A , Radley S et al (2016) . Health Technology Assessment, 20(88), 1-180.
• Franklin M, Wailoo A, Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB & Thornhill MH (2016) . Circulation, 134(20), 1568-1578.
• Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) . Health Technology Assessment, 20(35), 611-614.
• Brown SR, Tiernan JP, Watson AJM, Biggs K, Shephard N, Wailoo AJ, Bradburn M, Alshreef A & Hind D (2016) . The Lancet, 388(10042), 356-364.
• Stevenson M, Archer R, Tosh J, Simpson E, Everson-Hock E, Stevens J, Hernandez-Alava M, Paisley S, Dickinson K, Scott D , Young A et al (2016) . Health Technology Assessment, 20(35), 1-610.
• Madan J, Ades T, Barton P, Bojke L, Choy E, Helliwell P, Jobanputra P, Stein K, Stevens A, Tosh J , Verstappen S et al (2015) . Rheumatology and Therapy, 2(2), 113-125.
• Wailoo A, Hernández M, Philips C, Brophy S & Siebert S (2015) . Value in Health, 18(4), 425-431.
• Shah KK, Tsuchiya A & Wailoo AJ (2015) . Social Science & Medicine, 124, 48-56.
• Skedgel C, Wailoo A & Akehurst R (2015) . Medical Decision Making, 35(1), 94-105.
• Skedgel CD, Wailoo AJ & Akehurst RL (2015) . Health Expect, 18(5), 1227-1240.
• Alava MH & Wailoo A (2015) . The Stata Journal: Promoting communications on statistics and Stata, 15(3), 737-750.
• Wailoo A, Hernández Alava M, Scott IC, Ibrahim F & Scott DL (2014) . Rheumatology (Oxford), 53(10), 1773-1777.
• Norton S, Fu B, Scott DL, Deighton C, Symmons DPM, Wailoo AJ, Tosh J, Lunt M, Davies R, Young A & Verstappen SMM (2014) . Semin Arthritis Rheum, 44(2), 131-144.
• Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2014) . Med Decis Making, 34(7), 919-930.
• Poku E, Rathbone J, Everson-Hock E, Essat M, Wong R, Pandor A & Wailoo A (2014) . BMJ Open, 4.
• Shah KK, Tsuchiya A & Wailoo AJ (2014) . Eur J Health Econ, 15(4), 389-399.
• Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, Akehurst RL & Campbell MJ (2014) . Med Decis Making, 34(3), 387-402.
• Wailoo A, Hernandez Alava M & Escobar Martinez A (2014) . Health Qual Life Outcomes, 12, 37.
• Houten R, Wailoo A, Jonsson P & McLeod C (2014) . Prim Health Care Res Dev, 15(1), 111-116.
• Johannesen KM, Claxton K, Sculpher MJ & Wailoo AJ (2013) . VALUE IN HEALTH, 16(7), A489-A489.
• Wailoo AJ, Hernandez M & Escobar Martinez A (2013) . VALUE IN HEALTH, 16(7), A606-A606.
• Kearns B, Ara R, Wailoo A, Manca A, Alava MH, Abrams K & Campbell M (2013) . Pharmacoeconomics, 31(8), 643-652.
• Hernández Alava M, Wailoo A, Wolfe F & Michaud K (2013) . Rheumatology (Oxford), 52(5), 944-950.
• Davis S & Wailoo A (2013) . Health Qual Life Outcomes, 11, 20.
• Ara R & Wailoo AJ (2013) . Med Decis Making, 33(2), 139-153.
• Tiernan J, Hind D, Watson A, Wailoo AJ, Bradburn M, Shephard N, Biggs K & Brown S (2012) . BMC Gastroenterol, 12, 153.
• Scott IC, Wailoo A & Scott DL (2012) Payers' views on treating-to-target in rheumatoid arthritis: an English perspective.. Clin Exp Rheumatol, 30(4 Suppl 73), S85-S90.
• Ara R & Wailoo A (2012) . Value Health, 15(6), 971-974.
• Hernández Alava M, Wailoo AJ & Ara R (2012) . Value Health, 15(3), 550-561.
• Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A , Jeffreys M et al (2012) . Health Technol Assess, 16(21), 1-470.
• Shah K, Wailoo AJ & Tsuchiya A (2011) Valuing Health at the End of Life: An Exploratory Preference Elicitation Study.
• Morden JP, Lambert PC, Latimer N, Abrams KR & Wailoo AJ (2011) . BMC Med Res Methodol, 11, 4.
• Sampson F, Goodacre S, Carter A & Wailoo A (2011) . Journal of Paramedic Practice, 3(11), 625-631.
• Wailoo AJ, Hernandez M & Ara R (2011) . VALUE IN HEALTH, 14(7), A242-A242.
• Ara R & Wailoo AJ (2011) . VALUE IN HEALTH, 14(7), A425-A425.
• Tosh J, Brennan A, Wailoo A & Bansback N (2011) . Rheumatology (Oxford), 50 Suppl 4, iv26-iv31.
• Melandri G (2011) . Heart, 97(2), 163-163.
• Tosh JC, Wailoo AJ, Scott DL & Deighton CM (2011) . J Rheumatol, 38(8), 1593-1600.
• Wailoo A, Goodacre S & Sampson F (2011) . HEART, 97(2), 163-163.
• Hind D, Wailoo AJ & Sutcliffe P (2011) . Health Expect, 14(1), 38-47.
• Lloyd S, Bujkiewicz S, Wailoo AJ, Sutton AJ & Scott D (2010) . Rheumatology (Oxford), 49(12), 2313-2321.
• Wailoo A, Goodacre S, Sampson F, Alava MH, Asseburg C, Palmer S, Sculpher M, Abrams K, de Belder M & Gray H (2010) . Heart, 96(9), 668-672.
• Wailoo A, Sutton A & Morgan A (2009) . Br J Cancer, 100(3), 436-441.
• Wailoo A, Tsuchiya A & McCabe C (2009) . Pharmacoeconomics, 27(12), 983-989.
• Wailoo A, Bansback N & Chilcott J (2008) . RHEUMATOLOGY, 47(10), 1590-1590.
• Wailoo AJ, Bansback N, Brennan A, Michaud K, Nixon RM & Wolfe F (2008) . Arthritis Rheum, 58(4), 939-946.
• Cheater FM, Baker R, Gillies C, Wailoo A, Spiers N, Reddish S, Robertson N & Cawood C (2008) . Int J Nurs Stud, 45(3), 339-351.
• Wailoo AJ, Sutton AJ, Cooper NJ, Turner DA, Abrams KR, Brennan A & Nicholson KG (2008) . Value Health, 11(2), 160-171.
• Wailoo A, Bansback N & Chilcott J (2008) . Rheumatology (Oxford), 47(2), 119-120.
• Oluboyede Y, Goodacre S, Wailoo A & ESCAPE Research Team (2008) . BMC Health Serv Res, 8, 174.
• Dolan P, Edlin R, Tsuchiya A & Wailoo A (2007) . J ECON BEHAV ORGAN, 64(1), 157-170.
• Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ & Thomas S (2006) Optimal algorithm for evaluating suspected DVT. J FAM PRACTICE, 55(9), 754-754.
• Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A , O'Hagan A et al (2006) The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review. HEALTH TECHNOL ASSES, 10(24), 1-+.
• Cheater FM, Baker R, Reddish S, Spiers N, Wailoo A, Gillies C, Robertson N & Cawood C (2006) . Med Care, 44(6), 542-551.
• Goodacre S, Stevenson M, Wailoo A, Sampson F, Sutton AJ & Thomas S (2006) . QJM, 99(6), 377-388.
• Goodacre S, Sampson F, Stevenson M, Wailoo A, Sutton A, Thomas S, Locker T & Ryan A (2006) Measurement of the clinical and cost-effectiveness of non-invasive diagnostic testing strategies for deep vein thrombosis.. Health technology assessment (Winchester, England), 10(15).
• Turner DA, Wailoo AJ, Cooper NJ, Sutton AJ, Abrams KR & Nicholson KG (2006) . Vaccine, 24(7), 1035-1043.
• Connock M, Burls A, Frew E, Fry-Smith A, Juarez-Garcia A, McCabe C, Wailoo A, Abrams K, Cooper N, Sutton A , O'Hagan A et al (2006) The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.. Health technology assessment (Winchester, England), 10(24).
• Goodacre S, Sampson F, Stevenson M, Wailoo A, Sutton A, Thomas S, Locker T & Ryan A (2006) . Health Technology Assessment, 10(15).
• Wailoo A & Anand P (2005) . Soc Sci Med, 60(2), 223-236.
• Tsuchiya A, Miguel LS, Edlin R, Wailoo A & Dolan P (2005) . Appl Health Econ Health Policy, 4(2), 119-127.
• Littlejohns P, Leng G, Culyer T & Drummond M (2004) . BMJ, 329(7465), 571.1-571.1.
• Wailoo A, Roberts J, Brazier J & McCabe C (2004) . British Medical Journal, 328(7439), 536-537.
• Littlejohns P, Leng G, Culyer T, Drummond M, Pilling S, Dutchak J, McInnes E, Macbeth F, Pearson M, Thomas J , Turnbull N et al (2004) NICE clinical guidelines [2] (multiple letters). British Medical Journal, 329(7465), 571-572.
• Riley RD, Heney D, Jones DR, Sutton AJ, Lambert PC, Abrams KR, Young B, Wailoo AJ & Burchill SA (2004) . Clin Cancer Res, 10(1 Pt 1), 4-12.
• Wailoo AJ, Turner D, Cooper N, Sutton A, Abrams K & Nicholson K (2003) Cost-effectiveness and value of information analyses of the use of antivirals for the treatment of influenza in healthy adults. VALUE HEALTH, 6(6), 755-755.
• Dolan P, Tsuchiya A & Wailoo A (2003) NICE's citizen's council: what do we ask them, and how?. LANCET, 362(9387), 918-919.
• Cooper NJ, Sutton AJ, Abrams KR, Wailoo A, Turner DA & Nicholson KG (2003) Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials. BRIT MED J, 326(7401), 1235-+.
• Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A & Abrams K (2003) Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.. Health technology assessment (Winchester, England), 7(35).
• Riley RD, Burchill SA, Abrams KR, Heney D, Lambert PC, Jones DR, Sutton AJ, Young B, Wailoo AJ & Lewis IJ (2003) A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma.. Health technology assessment (Winchester, England), 7(5), 1-162.
• Turner D, Wailoo A, Nicholson K, Cooper N, Sutton A & Abrams K (2003) Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technology Assessment, 7(35).
• Riley RD, Burchill SA, Abrams KR, Heney D, Lambert PC, Jones DR, Sutton AJ, Young B, Wailoo AJ & Lewis IJ (2003) A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma. Health Technology Assessment, 7(5).
• Riley RD, Burchill SA, Abrams KR, Heney D, Sutton AJ, Jones DR, Lambert PC, Young B, Wailoo AJ & Lewis IJ (2003) . Eur J Cancer, 39(1), 19-30.
• Riley RD, Burchill SA, Abrams KR, Heney D, Lambert PC, Jones DR, Sutton AJ, Young B, Wailoo AJ & Lewis IJ (2003) . Health Technol Assess, 7(5), 1-162.
• Shields MA & Wailoo A (2002) Exploring the determinants of unhappiness for ethnic minority men in Britain. SCOT J POLIT ECON, 49(4), 445-466.
• Anand P & Wailoo A (2000) Utilities versus rights to publicly provided goods: Arguments and evidence from health care rationing. ECONOMICA, 67(268), 543-577.
• Wickramasekera N, Hole AR, Rowen D, Wailoo A & Keetharuth AD () Exploring the factors that drive clinical negligence claims: stated preferences of those who have experienced unintended harm. Patient: Patient-Centered Outcomes Research.
• Hernández Alava M, Pudney S & Wailoo A () . PharmacoEconomics.
• Keetharuth D, Hussain H, Rowen D & Wailoo A () Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review. Health and Quality of Life Outcomes.
• Peasgood T, Mukuria C, Rowen D, Tsuchiya A & Wailoo A () Should we consider including a value for ‘hope’ as an additional benefit within HTA?. Value in Health.
• Hernández Alava M, Wailoo A, Pudney S, Gray L & Manca A () . Health Technology Assessment, 24(34), 1-68.
• Cox M, O’Connor C, Biggs K, Hind D, Bortolami O, Franklin M, Collins B, Walters S, Wailoo A, Channell J , Albert P et al () . Health Technology Assessment, 22(11), 1-204.
• Connock M, Juarez-Garcia A, Frew E, Mans A, Dretzke J, Fry-Smith A & Moore D () . Health Technology Assessment, 10(20).
• Hock ES, Martyn-St James M, Wailoo A, Scott DL, Stevenson M, Rawdin A, Simpson EL, Dracup N & Young A () . SN Comprehensive Clinical Medicine.
• Gray L, Hernandez M & Wailoo A () Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer. BMC Cancer.
• Wailoo A, Hernandez M, Chrysanthou G, Barcelos F, van Gaalen F, Santos H, Fagerli K, Gago L, Margarida Cunha M, van de Sande M , Couto M et al () MEASURING QUALITY OF LIFE OF PATIENTS WITH AXIAL SPONDYLOARTHRITIS FOR ECONOMIC EVALUATION. RMD Open.
• Rafia R, Metry A & Wailoo A () A cost-effectiveness analysis of remdesivir for the treatment of hospitalised patients with COVID-19 in England and Wales. Value in Health.
• Rowen D, Mukuria C, Powell P & Wailoo A () Exploring the issues of valuing child and adolescent health states using a mixed sample of adolescents and adults. PharmacoEconomics.

Chapters

• Scott DL & Wailoo A (2020) , Oxford Textbook of Rheumatoid Arthritis (pp. 259-270). Oxford University Press
• Wailoo A (2010) , Clinical Guide to Primary Angioplasty (pp. 179-182). CRC Press
• Wailoo AJ (2010) Primary Angioplasty in Health Care Delivery: The Economics, CLINICAL GUIDE TO PRIMARY ANGIOPLASTY (pp. 179-182).

Conference proceedings papers

• Hussain H, Keetharuth A, Rowen D & Wailoo A (2023) Convergent validity of EQ-5D with core outcomes in dementia: a systematic review. QUALITY OF LIFE RESEARCH, Vol. 32(SUPPL 1) (pp S10-S10)
• Powell P, Rowen D, Mukuria C, Keetharuth A & Wailoo A (2022) Valuing health-related quality of life in children and adolescents: Who should we ask and how? A study protocol for consulting the public and experts in health valuation. QUALITY OF LIFE RESEARCH, Vol. 31 (pp S146-S146)
• Metry A, Rafia R & Wailoo A (2022) ECONOMIC EVALUATION OF NEUTRALISING MONOCLONAL ANTIBODIES FOR THE TREATMENT OF COVID-19 POSITIVE PEOPLE IN THE COMMUNITY. VALUE IN HEALTH, Vol. 25(7) (pp S395-S395)
• Hill H, Rowen D, Pennington B, Wong R & Wailoo A (2019) Are child and adolescent-specific measures used to inform resource allocation decisions? A review of the methods used to generate utility values in NICE technology appraisals for children and adolescents. QUALITY OF LIFE RESEARCH, Vol. 28 (pp S110-S110)
• Alshreef A, Latimer N, Tappenden P, McKane W, Wong R, Hughes D, Wailoo A, White I, Fotheringham J & Dixon S (2018) Adjusting the causal effects of treatments in the presence of patient non-adherence: a systematic review of methodological papers. European Society for Patient Adherence, Compliance and Persistence, Dublin, 29 November 2018 - 1 December 2018.
• Alshreef A & Wailoo A (2017) . Value in Health, Vol. 20(9) (pp A666-A666)
• Luqmani RA, Lee E, Singh S, Gillett M, Schmidt W, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W , Masters S et al (2016) ULTRASOUND COMPARED WITH BIOPSY IN THE DIAGNOSIS OF SUSPECTED GIANT CELL ARTERITIS. RHEUMATOLOGY, Vol. 55 (pp 37-37)
• Luqmani RA, Lee E, Singh S, Gillett M, Schmidt WA, Bradburn M, Dasgupta B, Diamantopoulos AP, Forrester-Barker W, Hamilton W , Masters S et al (2016) INTERRATER AND INTRARATER ANALYSIS OF ULTRASOUND AND HISTOLOGICAL FINDINGS IN PATIENTS WITH SUSPECTED GIANT CELL ARTERITIS. RHEUMATOLOGY, Vol. 55 (pp 171-171)
• Wailoo AJ, Stevenson M, Tosh J, Hernández M, Stevens JW, Archer R, Simpson E, everson HE, Scott D, Young A , Paisley S et al (2014) . Value in Health, Vol. 17(7) (pp A380-A380)
• Boucher R, Abrams KR, Crowther MJ, Lambert PC, Wailoo AJ & Latimer NR (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A610-A611)
• Latimer NR, Abrams KR, Lambert PC, Crowther MJ, Wailoo AJ, Morden JP, Akehurst RL & Campbell MJ (2013) . VALUE IN HEALTH, Vol. 16(7) (pp A325-A325)
• Norton S, Fu B, Verstappen SMM, Symmons DPM, Lunt M, Davies R, Scott DL, Deighton C, Wailoo AJ, Tosh J & Young A (2013) . ANNALS OF THE RHEUMATIC DISEASES, Vol. 71 (pp 508-508)
• Latimer N, Lambert P, Crowther M, Abrams KR, Wailoo AJ & Morden JP (2012) . VALUE IN HEALTH, Vol. 15(7) (pp A462-A462)
• Tosh J & Wailoo A (2009) COMBINATION DMARDS FOR RHEUMATOID ARTHRITIS: A COST-EFFECTIVENESS ANALYSIS. RHEUMATOLOGY, Vol. 48 (pp I68-I69)
• Cooper NJ, Sutton AJ, Abrams KR, Turner D & Wailoo A (2004) . HEALTH ECONOMICS, Vol. 13(3) (pp 203-226)

Reports

• Keetharuth A, Wong R, Hill J, Rowen D & Wailoo A (2023) Health related quality of life in economic evaluations in dementia: state of play and reflections
• Donna R, Brazier J, Hill H, Keetharuth A, Mukuria C, Peasgood T, Wailoo A, Wong R & Hill J (2022) Scoping, assessing feasibility, preliminary research and prioritising projects for the outcome measurement and valuation
• Hill H, Rowen D, Keetharuth A, Wailoo A & Hill J (2022) A literature review of methods to measure and value benefits in cost-effectiveness analyses of interventions for patients with either a short life expectancy or receiving palliative care’
• Rowen D, Mukuria C, Powell P, Wong R & Wailoo A (2021) Valuing child health: Exploring the use of a mixed sample of adolescents and adults to value child and adolescent health states
• Rowen D, Brazier J, Wong R & Wailoo A (2020) Measuring and valuing health-related quality of life when sufficient EQ-5D data is not available
• Rowen D, Keetharuth D, Poku E, Wailoo A, Wong R, Pennington R & Brazier J (2019) A review of the psychometric performance of paediatric preference-based measures used to generate utility values for children
• Hill JH, Rowen D, Pennington R, Wailoo A & Wong R (2019) A review of the methods used to generate utility values in NICE technology appraisals for paediatrics

Scholarly editions

• Hernández-Alava M, Sampson C & Wailoo A (2013) Happy and healthy: a joint model of health and life satisfaction.
• Claxton K, Eggington S, Ginnelly L, Griffin S, McCabe C, Philips Z, Tappenden P & Wailoo A A Pilot Study of Value of Information Analysis to Support Research Recommendations for the National Institute for Health and Clinical Excellence.
• Anand P & Wailoo A Utilities vs. Rights to Publicly Provided Goods: Arguments and Evidence from Health-Care Rationing.
• Shields M & Wailoo A Unhappiness and Involuntary Unemployment: The Case of Ethnic Minority Men in Britain.

Posters

• Poku E, Rathbone J, Hock E, Essat M, Wong R, Pandor A & Wailoo A (2013) Safety of intravitreal bevacizumab as a monotherapy in ophthalmic conditions: systematic review. Health Technology Assessment International.
• Ara R & Wailoo A A review of methods used to estimate mean preference-based utilities for comorbidities using published summary statistics.
• ALAVA MH & Wailoo A Estimating EQ-5D health states values for Rheumatoid Arthritis patients: a limited dependent variable, mixture modelling approach (2012).

Preprints

• Shah K, Tsuchiya A, Hole AR & Wailoo AJ () .
• Shah K, Wailoo AJ & Tsuchiya A () .